5α-Androstane-3β,17β-diol (3β-diol), an estrogenic metabolite of 5α-dihydrotestosterone, is a potent modulator of estrogen receptor ERβ expression in the ventral prostrate of adult rats

Steroids

Volumn 72, Issue 14, 2007, Pages 914-922

  Oliveira, André G ^a   Coelho, Polyanna H ^a   Guedes, Fernanda D ^a   Mahecha, Germán A B ^a   Hess, Rex A ^b   Oliveira, Cleida A ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

3 Diol; Androgen receptor; Estrogen receptor; Prostate

Indexed keywords

17 BETA ESTRADIOL 3 BENZOATE; 3BETA ANDROSTANEDIOL; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANDROSTANOLONE BROMOACETATE; AROMATASE; ESTRADIOL; ESTROGEN RECEPTOR BETA; UNCLASSIFIED DRUG; ANDROSTANEDIOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; CASTRATION; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; ESCHERICHIA COLI; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROSTATE VENTRAL LOBE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING; ANIMAL; BODY WEIGHT; CELL NUCLEUS; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HISTOLOGY; METABOLISM; ORCHIECTOMY; ORGAN SIZE; PROSTATE; WISTAR RAT;

RATTUS;

ANDROSTANE-3,17-DIOL; ANIMALS; BODY WEIGHT; CELL NUCLEUS; DIHYDROTESTOSTERONE; EPITHELIAL CELLS; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; HORMONE REPLACEMENT THERAPY; MALE; ORCHIECTOMY; ORGAN SIZE; PROSTATE; RATS; RATS, WISTAR; RECEPTORS, ANDROGEN;

EID: 35348931001     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.08.001     Document Type: Article

References (53)

1. Sar M., Lubahn D.B., French F.S., and Wilson E.M. Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127 (1990) 3180-3186
2. Prins G.S., Birch L., and Greene G.L. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129 (1991) 3187-3199
3. Prins G.S., Marmer M., Woodham C., Chang W., Kuiper G., Gustafsson J.A., et al. Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139 (1998) 874-883
4. Weihua Z., Andersson S., Cheng G., Simpson E.R., Warner M., and Gustafsson J.A. Update on estrogen signaling. FEBS Lett 546 (2003) 17-24
5. Voigt K.D., and Bartsch W. Intratissular androgens in benign prostatic hyperplasia and prostatic cancer. J Steroid Biochem 25 (1986) 749-757
6. Brodie A.M., Son C., King D.A., Meyer K.M., and Inkster S.E. Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism. Cancer Res 49 (1989) 6551-6555
7. Ellem S.J., Schmitt J.F., Pedersen J.S., Frydenberg M., and Risbridger G.P. Local aromatase expression in human prostate is altered in malignancy. J Clin Endocrinol Metab 89 (2004) 2434-2441
8. Takase Y., Levesque M.H., Luu-The V., El-Alfy M., Labrie F., and Pelletier G. Expression of enzymes involved in estrogen metabolism in human prostate. J Histochem Cytochem 54 (2006) 911-921
9. Tamm J., Volkwein U., Kurniawan E., and Becker H. Concentrations of unconjugated 5 alpha-androstane-3 alpha, 17 beta-diol and 5 alpha-androstane-3 beta, 17 beta-diol and their precursor in human testicular tissue. Comparison with testosterone, 5 alpha-dihydrotestosterone, estradiol-17 beta, and with steroid concentrations in human epididymis. J Steroid Biochem 26 (1987) 345-348
10. Weihua Z., Lathe R., Warner M., and Gustafsson J.A. An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99 (2002) 13589-13594
11. Steckelbroeck S., Jin Y., Gopishetty S., Oyesanmi B., and Penning T.M. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J Biol Chem 279 (2004) 10784-10795
12. Bauman D.R., Steckelbroeck S., Peehl D.M., and Penning T.M. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer. Endocrinology 147 (2006) 5806-5816
13. Penning T.M., Bauman D.R., Jin Y., and Rizner T.L. Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor. Mol Cell Endocrinol 265-266 (2007) 77-82
14. Krieg M., Horst H.J., and Sterba M.L. Binding and metabolism of 5alpha-androstane-3alpha, 17 beta-diol and of 5alpha-androstane-3beta, 17 beta-diol in the prostate, seminal vesicles and plasma of male rats: studies in vivo and in vitro. J Endocrinol 64 (1975) 529-538
15. Bauman D.R., Steckelbroeck S., Williams M.V., Peehl D.M., and Penning T.M. Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha, 17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease. Mol Endocrinol 20 (2006) 444-458
16. Sundin M., Warner M., Haaparanta T., and Gustafsson J.A. Isolation and catalytic activity of cytochrome P-450 from ventral prostate of control rats. J Biol Chem 262 (1987) 12293-12297
17. Martin C., Ross M., Chapman K.E., Andrew R., Bollina P., Seckl J.R., et al. CYP7B generates a selective estrogen receptor beta agonist in human prostate. J Clin Endocrinol Metab 89 (2004) 2928-2935
18. Omoto Y., Lathe R., Warner M., and Gustafsson J.A. Early onset of puberty and early ovarian failure in CYP7B1 knockout mice. Proc Natl Acad Sci USA 102 (2005) 2814-2819
19. Morali G., Oropeza M.V., Lemus A.E., and Perez-Palacios G. Mechanisms regulating male sexual behavior in the rat: role of 3 alpha- and 3 beta-androstanediols. Biol Reprod 51 (1994) 562-571
20. Weihua Z., Makela S., Andersson L.C., Salmi S., Saji S., Webster J.I., et al. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 98 (2001) 6330-6335
21. Pak T.R., Chung W.C., Lund T.D., Hinds L.R., Clay C.M., and Handa R.J. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells. Endocrinology 146 (2005) 147-155
22. Picciarelli-Lima P., Oliveira A.G., Reis A.M., Kalapothakis E., Mahecha G.A., Hess R.A., et al. Effects of 3-beta-diol, an androgen metabolite with intrinsic estrogen-like effects, in modulating the aquaporin-9 expression in the rat efferent ductules. Reprod Biol Endocrinol 4 (2006) 51
23. Vreeburg J.T. Distribution of testosterone and 5alpha-dihydrotestosterone in rat epididymis and their concentrations in efferent duct fluid. J Endocrinol 67 (1975) 203-210
24. Kuiper G.G., Shughrue P.J., Merchenthaler I., and Gustafsson J.A. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol 19 (1998) 253-286
25. Imamov O., Morani A., Shim G.J., Omoto Y., Warner M., and Gustafsson J.A. Estrogen receptor-beta regulates epithelial cell differentiation in the mouse ventral prostate. Horm Res 62 Suppl. 3 (2004) 115
26. McPherson S.J., Ellem S.J., Simpson E.R., Patchev V., Fritzemeier K.H., and Risbridger G.P. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 148 (2007) 566-574
27. Pravettoni A., Mornati O., Martini P.G., Marino M., Colciago A., Celotti F., et al. Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells. Mol Cell Endocrinol 263 (2007) 46-54
28. Horvath L.G., Henshall S.M., Lee C.S., Head D.R., Quinn D.I., Makela S., et al. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 61 (2001) 5331-5335
29. Latil A., Bieche I., Vidaud D., Lidereau R., Berthon P., Cussenot O., et al. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 61 (2001) 1919-1926
30. Leav I., Lau K.M., Adams J.Y., McNeal J.E., Taplin M.E., Wang J., et al. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 159 (2001) 79-92
31. Pasquali D., Rossi V., Esposito D., Abbondanza C., Puca G.A., Bellastella A., et al. Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues. J Clin Endocrinol Metab 86 (2001) 2051-2055
32. Cheng J., Lee E.J., Madison L.D., and Lazennec G. Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 566 (2004) 169-172
33. Guerini V., Sau D., Scaccianoce E., Rusmini P., Ciana P., Maggi A., et al. The androgen derivative 5alpha-androstane-3beta, 17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Res 65 (2005) 5445-5453
34. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 95 (1998) 15677-15682
35. Fan X., and Robaire B. Orchidectomy induces a wave of apoptotic cell death in the epididymis. Endocrinology 139 (1998) 2128-2136
36. Oliveira C.A., Nie R., Carnes K., Franca L.R., Prins G.S., Saunders P.T., et al. The antiestrogen ICI 182,780 decreases the expression of estrogen receptor-alpha but has no effect on estrogen receptor-beta and androgen receptor in rat efferent ductules. Reprod Biol Endocrinol 1 (2003) 75
37. Kiplesund K.M., Halgunset J., Fjosne H.E., and Sunde A. Light microscopic morphometric analysis of castration effects in the different lobes of the rat prostate. Prostate 13 (1988) 221-232
38. Pelletier G. Effects of estradiol on prostate epithelial cells in the castrated rat. J Histochem Cytochem 50 (2002) 1517-1524
39. Asano K., Maruyama S., Usui T., and Fujimoto N. Regulation of estrogen receptor alpha and beta expression by testosterone in the rat prostate gland. Endocr J 50 (2003) 281-287
40. Nellemann C., Dalgaard M., Holst B., Bonefeld-Jorgensen E.C., and Vinggaard A.M. Gene expression changes in rat prostate after activation or blocking of the androgen and estrogen receptor. Mol Cell Endocrinol 237 (2005) 25-35
41. Ahmad N., Warren D.W., and Haltmeyer G.C. The effects of 5alpha-reduced androgens on maintenance and regeneration of prostate glands and seminal vesicles in castrated and hypophysectomized rats. Anat Rec 192 (1978) 543-554
42. Sharkevich I.N., Omel'chenko E.A., Koreneva E.M., and Brindak O.I. Comparison of morphological and biochemical indicators of prostatic growth and function in castrated rats receiving separately and simultaneously 5 alpha-dihydrotestosterone and 5 alpha-androstane-3 beta, 17 beta-diol. Probl Endokrinol (Mosk) 31 (1985) 58-61
43. Taylor R.A., Cowin P., Couse J.F., Korach K.S., and Risbridger G.P. 17beta-estradiol induces apoptosis in the developing rodent prostate independently of ERalpha or ERbeta. Endocrinology 147 (2006) 191-200
44. Shughrue P.J., Lane M.V., Scrimo P.J., and Merchenthaler I. Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 63 (1998) 498-504
45. Oliveira C.A., Mahecha G.A., Carnes K., Prins G.S., Saunders P.T., Franca L.R., et al. Differential hormonal regulation of estrogen receptors ERalpha and ERbeta and androgen receptor expression in rat efferent ductules. Reproduction 128 (2004) 73-86
46. Maggiolini M., Recchia A.G., Carpino A., Vivacqua A., Fasanella G., Rago V., et al. Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells. J Mol Endocrinol 32 (2004) 777-791
47. Sneddon S.F., Walther N., and Saunders P.T. Expression of androgen and estrogen receptors in sertoli cells: studies using the mouse SK11 cell line. Endocrinology 146 (2005) 5304-5312
48. Prins G.S., and Birch L. Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes after androgen withdrawal and replacement. Endocrinology 132 (1993) 169-178
49. Banerjee S., Banerjee P.P., Zirkin B.R., and Brown T.R. Regional expression of transforming growth factor-alpha in rat ventral prostate during postnatal development, after androgen ablation, and after androgen replacement. Endocrinology 139 (1998) 3005-3013
50. Yeap B.B., Krueger R.G., and Leedman P.J. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Endocrinology 140 (1999) 3282-3291
51. Woodham C., Birch L., and Prins G.S. Neonatal estrogen down-regulates prostatic androgen receptor through a proteosome-mediated protein degradation pathway. Endocrinology 144 (2003) 4841-4850
52. Bremner W.J., Millar M.R., Sharpe R.M., and Saunders P.T. Immunohistochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens. Endocrinology 135 (1994) 1227-1234
53. Zhu L.J., Hardy M.P., Inigo I.V., Huhtaniemi I., Bardin C.W., and Moo-Young A.J. Effects of androgen on androgen receptor expression in rat testicular and epididymal cells: a quantitative immunohistochemical study. Biol Reprod 63 (2000) 368-376